Rivaroxaban in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: Clinical Implications of the ROCKET AF Trial and Its Subanalyses
Crossref DOI link: https://doi.org/10.1007/s40256-015-0127-2
Published Online: 2015-06-11
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Spencer, Ryan J.
Amerena, John V.
Text and Data Mining valid from 2015-06-11